See every side of every news story
Published loading...Updated

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

  • On July 11, 2025, Guangzhou Concord Cancer Center completed China’s first proton therapy for choroidal malignant melanoma.
  • Guangzhou Concord Cancer Center uses advanced pencil beam scanning and real-time image guidance for effective treatment.
  • This treatment offers a new option to avoid enucleation, the standard procedure for choroidal malignant melanoma.
  • Guangzhou Concord Cancer Center is the first in China to provide this eye-preserving treatment option.
Insights by Ground AI
Does this summary seem wrong?

43 Articles

The Berkshire EagleThe Berkshire Eagle
+41 Reposted by 41 other sources
Center

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

BEIJING, July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources are Center
59% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Monday, July 14, 2025.
Sources are mostly out of (0)

Similar News Topics